Prostaglandins buffer ANG II-mediated increases in cytosolic calcium in preglomerular VSMC

American Journal of Physiology - Renal Physiology

Volumn 277, Issue 6 46-6, 1999, Pages

  Purdy, Kit E ^a   Arendshorst, William J ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

15 (S) 15 methyl prostaglandin E2; Adenosine 3',5' cyclic monophosphate; Afferent arteriole; Angiotensin II; Cyclooxygenase; Fura 2; Iloprost; Indomethacin; Phosphodiesterase; Prostaglandin E2; Prostaglandin I2; Renal circulation; Vascular smooth muscle cells

Indexed keywords

ANGIOTENSIN; CALCIUM; CYCLIC AMP; INDOMETACIN; PROSTACYCLIN; PROSTAGLANDIN E2;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; DOSE RESPONSE; KIDNEY CIRCULATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT; REGULATORY MECHANISM; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

EID: 0033379161     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1999.277.6.f850     Document Type: Article

References (39)

1. Arendshorst, W. J., C. Chatziantoniou, and F. H. Daniels. Role of angiotensin II in the renal vasoconstriction observed during the development of genetic hypertension. Kidney Int. 38, Suppl. 30: S92-S96, 1990.
2. Baylis C., and B. M. Brenner. Modulation by prostaglandin synthesis inhibitors of the action of exogenous angiotensin II on glomerular ultrafiltration in the rat. Circ. Res. 43: 889-898, 1978.
3. Blasingham, M. C., and A. Nasjlettti. Differential renal effects of cyclooxygenase inhibition in sodium replete and sodium deprived dog. Am. J. Physiol. 239 (Renal Fluid Electrolyte Physiol. 8): F360-F365, 1980.
4. Brannon, T., A. North, L. Wells, and P. Shaul. Prostacyclin synthesis in ovine pulmonary artery is developmentally regulated by changes in cyclooxygenase-1 gene expression. J. Clin. Invest. 93: 2230-2235, 1994.
5. Catalioto, R., A. Renzetti, M. Criscuoli, L. Morbidelli, and A. Subissi. Role of calcium in angiotensin II-induced prostaglandin release and DNA synthesis in rat vascular smooth muscle cells. J. Cardiol. Pharmacol. 27: 195-200, 1996.
6. Chatziantoniou, C., and W. J. Arendshorst. Impaired ability of prostaglandins to buffer renal vasoconstriction in genetically hypertensive rats. Am. J. Physiol. 263 (Renal Fluid Electrolyte Physiol. 32): F573-F580, 1992.
7. Chatziantoniou, C., and W. J. Arendshorst. Angiotensin receptor sites in renal vasculature of rats developing genetic hypertension. Am. J. Physiol. 265 (Renal Fluid Electrolyte Physiol. 34): F853-F862, 1993.
8. Chatziantoniou, C., X. Ruan, and W. J. Arendshorst. Defective G protein activation of the cAMP pathway in rat kidney during genetic hypertension. Proc. Natl. Acad. Sci. USA 92: 2924-2928, 1995.
9. 2 receptors in the rabbit renal preglomerular microvasculature. Biochim. Biophys. Acta 1053: 156-161, 1990.
10. Conger, J. D., S. A. Falk, and J. B. Robinette. Angiotensin II-induced changes in smooth muscle calcium in rat renal arterioles. J. Am. Soc. Nephrol. 3: 1792-1803, 1993.
11. 2 stimulated signal transduction in vascular smooth muscle. J. Pharmacol. Exp. Ther. 265: 447-456, 1993.
12. Fellner, S. K., and W. J. Arendshorst. Capacitative calcium entry in smooth muscle cells from preglomerular vessels. Am. J. Physiol. 277 (Renal Physiol. 46): F533-F542, 1999.
13. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440-3450, 1985.
14. Hassid, A., and C. Williams. Vasoconstrictor-evoked prostaglandin synthesis in cultured vascular smooth muscle. Am. J. Physiol. 245 (Cell Physiol 14): C278-C282, 1983.
15. 2 and modulation by lipoxygenase and P-450 pathways. Am. J. Physiol. 273 (Renal Physiol. 42): F274-F282, 1997.
16. 2+ from intrarenal stores. Hypertension 29: 222-227, 1997.
17. Iversen, B. M., and W. J. Arendshorst. ANG II and vasopressin stimulate calcium entry in dispersed smooth muscle cells of preglomerular arterioles. Am. J. Physiol. 274 (Renal Physiol. 43): F498-F508, 1998.
18. 2 interactions in spontaneously hypertensive rats. Hypertension 22: 688-698, 1993.
19. Juncos, L. A., Y. Ren, S. Arima, J. Garvin, O. A. Carretero, and S. Ito. Angiotensin II action in isolated microperfused rabbit afferent arterioles is modulated by flow. Kidney Int. 49: 374-381, 1996.
20. Kirschenbaum, M. A., and A. Chaudhari. Calcium dependent synthesis of vasodilator renal microvascular prostanoids. Am. J. Nephrol. 6, Suppl. 1: 46-53, 1986.
21. Komhoff, M., H.-J. Grone, T. Klein, H. W. Seyberth, and R. M. Nusing. Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. Am. J. Physiol. 272 (Renal Physiol. 41): F460-F468, 1997.
22. McGiff, J. C. Prostaglandins, prostacyclin and thromboxanes. Annu. Rev. Pharmacol. Toxicol. 21: 479-551, 1981.
23. Murray, K. J. Cyclic AMP and mechanisms of vasodilation. Pharmacol. Ther. 47: 329-345, 1990.
24. 2+ levels and muscle contraction in isolated guinea pig aorta. Jpn. J. Pharmacol. 71: 231-237, 1996.
25. Palmer, B. F., and W. L. Henrich. Clinical acute renal failure with nonsteroidal anti-inflammatory drugs. Semin. Nephrol. 15: 214-227, 1995.
26. Ruan, X., and W. J. Arendshorst. Relative roles of calcium entry and mobilization signaling pathways in angiotensin II-induced constriction of renal resistance vessels in vivo. Am. J. Physiol. 270 (Renal Fluid Electrolyte Physiol. 39): F398-F405, 1996.
27. 2 receptor and Gs protein stimulation of cAMP formation in preglomerular vessels of young SHR. Hypertension 34: 1134-1141, 1999.
28. Saito, F., M. T. Hori, Y. Ideguchi, M. Berger, M. Golub, N. Stern, and M. L. Tuck. 12-Lipoxygenase products modulate calcium signals in vascular smooth muscle cells. Hypertension 20: 138-143, 1992.
29. Sandner, P., M. Kornfeld, X. Ruan, W. J. Arendshorst, and A. Kurtz. Nitric oxide/cAMP interactions in the control of rat renal vascular resistance. Circ. Res. 84: 186-192, 1998.
30. ca channels of vascular smooth muscle cells: role of cAMP-dependant kinase. Am. J. Physiol. 271 (Cell Physiol. 40): C1203-C1211, 1996.
31. 2+ release by cAMP-dependent protein kinase in a living cell. Proc. Natl. Acad. Sci. USA 95: 1613-1617, 1998.
32. Thierauch, K., H. Dinter, and G. Stock. Prostaglandins and their receptors. II. Receptor structure and signal transduction. J. Hypertens. 12: 1-5, 1994.
33. 2 receptor-mediated contraction in rat aorta. J. Pharmacol. Exp. Ther. 284: 921-928, 1998.
34. Vallotton, M., and R. Wuthrich. The regulation of prostaglandins by vasoactive hormones in renal tubular and vascular smooth muscle cells. Agents Actions Suppl. 22: 27-35, 1987.
35. Vane, J. R., and R. M. Botting. Formation by the endothelium of prostacyclin, nitric oxide and endothelin. J. Lipid. Mediat. 6: 395-404, 1993.
36. Yoshida, H., T. Tamaki, Y. Aid, S. Kimura, I. Takenaka, and Y. Abe. Effect of angiotensin II on isolated rabbit afferent arterioles. Jpn. J. Pharmacol. 66: 457-464, 1994.
37. Zambraski, E. J. The effects of nonsteroidal anti-inflammatory drugs on renal function: experimental studies in animals. Semin. Nephrol. 15: 205-213, 1995.
38. Zhu, Z., and W. J. Arendshorst. Angiotensin II-receptor stimulation of cytosolic calcium concentration in cultured renal resistance arterioles. Am. J. Physiol. 271 (Renal Fluid Electrolyte Physiol. 40): F1239-F1247, 1996.
39. Zou, M., M. Jendral, and V. Ullrich. Prostaglandin endoperoxide-dependent vasospasm in bovine coronary arteries after nitration of prostacyclin synthase. Br. J. Pharmacol. 126: 1283-1292, 1999.